SMAS Stock Overview
Provides drug-free and non-surgical approach to movement disorders, musculoskeletal problems, and pain relief. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Somatic Systems, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.0001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | n/a |
| 3 Year Change | -99.00% |
| 5 Year Change | -99.00% |
| Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| SMAS | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | -2.7% | 1.2% |
| 1Y | n/a | -5.1% | 21.0% |
Return vs Industry: Insufficient data to determine how SMAS performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how SMAS performed against the US Market.
Price Volatility
| SMAS volatility | |
|---|---|
| SMAS Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 6.6% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 18.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: SMAS's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine SMAS's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | n/a | Steven Aronstein | www.somatics.org |
Somatic Systems, Inc. provides drug-free and non-surgical approach to movement disorders, musculoskeletal problems, and pain relief. The company offers a system that uses natural non-invasive movement techniques conducted through one-hour hands-on sessions, therapeutic exercises classes, and home exercises to relieve pain and limitation resulting from accident, trauma, and repetitive stress, including back pain, knee pain, joint problems, carpal tunnel syndrome, TMJ, scoliosis, bursitis, sciatica, headaches, tendonitis, and more. It also provides performance gains and injury prevention for casual and professional athletes.
Somatic Systems, Inc. Fundamentals Summary
| SMAS fundamental statistics | |
|---|---|
| Market cap | US$14.60k |
| Earnings (TTM) | -US$239.08k |
| Revenue (TTM) | US$107.42k |
0.0x
P/S Ratio0.0x
P/E RatioIs SMAS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SMAS income statement (TTM) | |
|---|---|
| Revenue | US$107.42k |
| Cost of Revenue | US$9.76k |
| Gross Profit | US$97.66k |
| Other Expenses | US$336.74k |
| Earnings | -US$239.08k |
Last Reported Earnings
Dec 31, 2008
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did SMAS perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/11 21:01 |
| End of Day Share Price | 2025/01/23 00:00 |
| Earnings | 2008/12/31 |
| Annual Earnings | 2008/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Somatic Systems, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.